QHSLab, Inc. (OTCQB: USAQ) CEO Troy Grogan on 2026 Growth Drivers and Primary Care Expansion

Why It Matters

QHS Lab’s high‑margin, reimbursable platform offers a scalable revenue boost for independent primary‑care doctors, positioning the company for rapid expansion and making it an attractive micro‑cap investment.

Key Takeaways

• QHS Lab targets independent primary‑care practices with digital behavioral‑vital monitoring.
• Platform captures depression, anxiety, pain, sleep data before each visit.
• Services generate 20‑30% additional revenue per practice via reimbursements.
• Company achieved post‑profitability 2025; Q4 growth 127% YoY.
• Gross margins exceed 65%; expansion plans focus on nationwide practice rollout.

Summary

In a Planet Micro Cap interview, QHS Lab CEO Troy Grogan outlined the company’s 2026 growth strategy centered on expanding its digital‑medicine platform across independent primary‑care practices. The firm’s solution records “behavioral vital signs” – metrics such as depression, anxiety, chronic pain and sleep quality – before each patient visit, feeding the data directly into electronic health records to improve clinical decisions.

Grogan emphasized that the platform not only enhances care but also creates a new revenue stream for physicians, boosting practice income by 20‑30% through reimbursable services. QHS Lab reported post‑profitability at the end of 2025, posted a 127% year‑over‑year revenue increase in the latest quarter, and maintains gross profit margins above 65%.

Key quotes highlighted the uniqueness of the offering: “We measure behavioral vital signs…providing a complete picture before, during, and after the visit.” The company positions itself as a single‑vendor solution, avoiding the fragmentation seen with point‑product apps, and aims to roll out its services to more practices nationwide.

For investors, the combination of high margins, rapid top‑line growth, and a scalable model that addresses declining primary‑care reimbursements signals a compelling upside. Successful execution could cement QHS Lab as a leading digital health partner for the fragmented independent practice market.

Original Description

In this interview, Troy Grogan, CEO of QHSLab, Inc. (OTCQB: USAQ), discusses the company's approach to digital medicine, focusing on behavioral vital signs and primary care. He highlights the company's growth, value proposition, and plans for 2026, providing insights into the future of healthcare technology.

Chapters:

00:00 Introduction to QHSLab, Inc.

03:13 Unique Approach to Primary Care

05:25 Value Catalysts for 2026

QHSLab, Inc. will be presenting at the upcoming Planet MicroCap Las Vegas 2026 powered by MicroCapClub. Register to attend here: https://www.meetmax.com/sched/event_130817/conference_home.html

For more information about QHSLab, Inc., please visit: https://www.qhslab.com/

The interview may contain forward looking statements about QHSLab, Inc. See QHSLab, Inc.'s periodic filings with the Securities and Exchange Commission for more complete information.

About QHSLab, Inc.

QHSLab, Inc. (OTCQB: USAQ) is a digital health infrastructure company supporting independent primary care practices through workflow-integrated digital screening, clinical decision support, and care management services. The Company’s platform is designed to help physicians identify and manage underdiagnosed behavioral health and chronic conditions while supporting reimbursable clinical activities that occur both during and outside traditional office visits. QHSLab generates revenue primarily through recurring service fees from participating medical practices. The Company also operates an allergy diagnostics and treatment service line under the AllergiEnd® brand. Learn more at www.qhslab.com.

Planet Microcap hosts the highest quality in-person microcap events in North America. The mission is to bring the best microcap investors, companies, and allocators together to gather, connect, and grow.; visit https://planetmicrocap.com/ to learn more about our Las Vegas and Toronto events.

This presentation is for informational purposes only and should not be construed as a recommendation to purchase or sell any security referenced herein. Planet MicroCap Holdings LLC and MicroCapClub LLC (collectively, “we” or “our”) are not licensed brokers nor registered investment advisors. We, our partners, contractors, members, subscribers, guests, or affiliates may or may not hold positions in one or more of the securities mentioned in this presentation and may trade in such securities at any time. We may have received cash compensation from one or more participants for presenting at past, present, or future events. We recommend you consult a licensed investment adviser, broker, or legal counsel before purchasing or selling any securities referenced in this presentation.